Capitalising on its execution of large export orders even in the face of COVID-19 constraints, VRL's annual sales grew to Rs 548.12 crore in 2020-21, a company statement said on Wednesday.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3vKVUzo
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Venus Remedies posts 61% increase in FY21 annual sales at Rs 548 crore
0 comments:
Post a Comment